|
|
Volumn 10, Issue 5, 2008, Pages 1-14
|
|
Rotavirus vaccines: How they work or don't work
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIGEN;
CAPSID PROTEIN;
INACTIVATED VIRUS VACCINE;
LIVE VACCINE;
NEUTRALIZING ANTIBODY;
PROTEIN VP2;
PROTEIN VP6;
RECOMBINANT PROTEIN;
RECOMBINANT PROTEIN VP6;
ROTAVIRUS VACCINE;
TOXIN;
UNCLASSIFIED DRUG;
VIRUS ANTIBODY;
VIRUS VACCINE;
ACTIVE IMMUNIZATION;
ADJUVANT THERAPY;
ADOPTIVE TRANSFER;
ANTIBODY TITER;
ARTICLE;
CD4+ T LYMPHOCYTE;
CD8+ T LYMPHOCYTE;
CELLULAR IMMUNITY;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
IMMUNIZATION;
INFECTION PREVENTION;
INFECTION SENSITIVITY;
NONHUMAN;
PASSIVE IMMUNIZATION;
PATHOGENESIS;
PRIORITY JOURNAL;
RISK REDUCTION;
ROTAVIRUS;
SEROTYPE;
VIRUS IMMUNITY;
VIRUS INFECTION;
VIRUS INHIBITION;
VIRUS LIKE AGENT;
VIRUS NEUTRALIZATION;
VIRUS PARTICLE;
VIRUS REPLICATION;
VIRUS SHEDDING;
VIRUS STRAIN;
VIRUS VIRULENCE;
ANIMALIA;
BOVINAE;
HUMAN ROTAVIRUS A;
MUS;
ROTAVIRUS;
|
|
EID: 40349116613
PISSN: 14623994
EISSN: 14623994
Source Type: Journal
DOI: 10.1017/S1462399408000574 Document Type: Article |
|
Times cited : (32)
|
|
References (81)
|
